The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, has sold 13,747 equity shares (0.01% of paid-up capital) through the open market on December 30, 2025. His personal holding reduced from 42,65,992 shares (2.62%) to 42,52,245 shares (2.61%). Along with Persons Acting in Concert (PAC) — Rohan Rashi Family Trust, Mrs. Mona Choudhari, Mr. Rohan Choudhari, and Ms. Rashi Choudhari — the combined promoter group holds 93,01,000 shares, or 5.71% of the company. The disclosure was filed under SEBI SAST Regulation 29(2), which mandates reporting of every acquisition or sale of shares by promoters.
This is a very small sale by a promoter with no material impact on ownership or control; the combined promoter group holding remains at 5.71%, so retail investors are unlikely to see any meaningful effect on share price or voting dynamics.